[go: up one dir, main page]

NL192721B - Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten. - Google Patents

Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.

Info

Publication number
NL192721B
NL192721B NL8502439A NL8502439A NL192721B NL 192721 B NL192721 B NL 192721B NL 8502439 A NL8502439 A NL 8502439A NL 8502439 A NL8502439 A NL 8502439A NL 192721 B NL192721 B NL 192721B
Authority
NL
Netherlands
Prior art keywords
derivatives
medicinal
processes
preparation
well
Prior art date
Application number
NL8502439A
Other languages
English (en)
Other versions
NL8502439A (nl
NL192721C (nl
Inventor
Gerard Lang
Jean Maignan
Serge Restle
Braham Shroot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from LU85531A external-priority patent/LU85531A1/fr
Priority claimed from LU85700A external-priority patent/LU85700A1/fr
Application filed by Oreal filed Critical Oreal
Publication of NL8502439A publication Critical patent/NL8502439A/nl
Publication of NL192721B publication Critical patent/NL192721B/nl
Application granted granted Critical
Publication of NL192721C publication Critical patent/NL192721C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/782—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic
    • C07C49/792—Ketones containing a keto group bound to a six-membered aromatic ring polycyclic containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/546—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Saccharide Compounds (AREA)
NL8502439A 1984-09-05 1985-09-05 Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten. NL192721C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
LU85531A LU85531A1 (fr) 1984-09-05 1984-09-05 Nouveaux derives du benzonorbornene,leur procede de preparation et compositions medicamenteuse et cosmetique les contenant
LU85700A LU85700A1 (fr) 1984-12-20 1984-12-20 Nouveaux derives du benzonorbornene,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
LU85531 1984-12-20
LU85700 1984-12-20

Publications (3)

Publication Number Publication Date
NL8502439A NL8502439A (nl) 1986-04-01
NL192721B true NL192721B (nl) 1997-09-01
NL192721C NL192721C (nl) 1998-01-06

Family

ID=26640307

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8502439A NL192721C (nl) 1984-09-05 1985-09-05 Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.

Country Status (10)

Country Link
US (4) US4783549A (nl)
JP (1) JP2618225B2 (nl)
BE (1) BE903183A (nl)
CA (2) CA1267153A (nl)
CH (1) CH667868A5 (nl)
DE (1) DE3531722C2 (nl)
FR (1) FR2569689B1 (nl)
GB (1) GB2164644B (nl)
IT (1) IT1203635B (nl)
NL (1) NL192721C (nl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2599031B1 (fr) * 1986-05-23 1988-07-22 Oreal Nouveaux composes naphtyl aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
FR2617476B1 (fr) * 1987-07-03 1989-11-17 Oreal Nouveaux derives polycycliques aromatiques, leur procede de preparation et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5194664A (en) * 1989-02-10 1993-03-16 Basf Aktiengesellschaft Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
US7655699B1 (en) 1992-04-22 2010-02-02 Eisai Inc. Compounds having selective activity for retinoid X receptors, and means for modulation of processes mediated by retinoid X receptors
US5324840A (en) * 1992-06-11 1994-06-28 Allergan, Inc. Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects
US6172115B1 (en) 1993-02-11 2001-01-09 Allergan Sales, Inc. Method for preventing onset of restenosis after angioplasty employing an RXR-specific retinoid
US5455265A (en) * 1993-02-11 1995-10-03 Allergan, Inc. Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors
CA2129773C (en) 1993-09-02 2007-05-01 Michael Klaus Aromatic carboxylic acid derivatives
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
KR100625255B1 (ko) * 1995-10-06 2008-01-30 리간드 파마슈티칼스 인코포레이티드 다이머-선택적rxr변조물질및그의사용방법
AU8588798A (en) * 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
WO1999063980A1 (en) * 1998-06-12 1999-12-16 Ligand Pharmaceuticals Inc. Treatment of anti-estrogen resistant breast cancer using rxr modulators
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
CN1391576A (zh) 1999-08-27 2003-01-15 利甘德药品公司 雄激素受体调节剂化合物及方法
CA2378298A1 (en) 1999-08-27 2001-03-08 Lawrence G. Hamann 8-substituted-6-trifluoromethyl-9-pyrido¬3,2-g|quinoline compounds as androgen receptor modulators
WO2001019770A2 (en) 1999-09-14 2001-03-22 Ligand Pharmaceuticals Incorporated Rxr modulators with improved pharmacologic profile
US9050310B2 (en) * 2004-06-25 2015-06-09 Minas Theodore Coroneo Treatment of ocular lesions
US20060204474A1 (en) * 2005-02-25 2006-09-14 Coroneo Minas T Treatment of epithelial layer lesions
WO2012076842A1 (en) * 2010-12-09 2012-06-14 University Of Durham Synthetic retinoids for control of cell differentiation
ES2610564T3 (es) * 2011-12-21 2017-04-28 Firmenich Sa Odorizantes amaderados
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
KR102232806B1 (ko) 2013-02-28 2021-03-29 더미라, 인코포레이티드 글리코피롤레이트 염
US11045441B2 (en) 2015-10-13 2021-06-29 Wisconsin Alumni Research Foundation Use of retinoic acid and analogs thereof to treat central neural apneas

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU77254A1 (nl) * 1977-05-04 1979-01-18
US4326055A (en) * 1977-12-22 1982-04-20 Hoffmann-La Roche Inc. Stilbene derivatives
FI67386C (fi) * 1979-06-21 1985-03-11 Hoffmann La Roche Foerfarande foer framstaellning av nya terapeutiskt anvaendbara sockerderivat
DE3202100A1 (de) * 1982-01-23 1983-08-04 Basf Ag, 6700 Ludwigshafen Substituierte benzoesaeure-4-hydroxyanilide, ihre herstellung und diese enthaltende pharmazeutische zubereitungen
US4439614A (en) * 1982-09-22 1984-03-27 Sri International 5,6-Methano-5,6-dihydroretinoids
EP0155940A1 (en) * 1983-08-08 1985-10-02 Sri International Benzonorbornenyl, benzopyranyl and benzothiopyranyl retinoic acid analogues

Also Published As

Publication number Publication date
NL8502439A (nl) 1986-04-01
CA1267153A (fr) 1990-03-27
DE3531722C2 (de) 1995-07-06
GB2164644A (en) 1986-03-26
US4931589A (en) 1990-06-05
IT1203635B (it) 1989-02-15
US5198567A (en) 1993-03-30
FR2569689A1 (fr) 1986-03-07
IT8567757A0 (it) 1985-09-05
CA1272448A (fr) 1990-08-07
US5053547A (en) 1991-10-01
NL192721C (nl) 1998-01-06
DE3531722A1 (de) 1986-03-06
GB2164644B (en) 1988-04-27
FR2569689B1 (fr) 1990-11-16
BE903183A (fr) 1986-03-05
JPS61126038A (ja) 1986-06-13
CH667868A5 (fr) 1988-11-15
GB8522082D0 (en) 1985-10-09
US4783549A (en) 1988-11-08
JP2618225B2 (ja) 1997-06-11

Similar Documents

Publication Publication Date Title
NL192721B (nl) Benzonorborneenderivaten, werkwijzen voor het bereiden ervan alsmede geneeskundige en cosmetische preparaten, die dergelijke derivaten bevatten.
NL190552C (nl) 1-Fenyl-4-alkyl-7,8-dialkoxy-5H-2,3-benzodiazepinederivaten en farmaceutische preparaten, die deze bevatten.
NL930061I2 (nl) Anti-fungus-middelen, werkwijze ter bereiding daarvan en farmaceutische preparaten, die deze anti-fungus-middelen bevatten.
NL191738C (nl) ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten.
NL190844C (nl) Sulfoniumverbindingen, werkwijzen voor de bereiding van deze verbindingen en farmaceutische preparaten, die deze verbindingen bevatten.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
NL300045I2 (nl) Fluorcytidine-derivaten, de bereiding daarvan en geneesmiddelen die deze derivaten bevatten.
NL193819B (nl) Naftaleenderivaten alsmede farmaceutische en cosmetische preparaten, die deze derivaten bevatten.
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NL8601838A (nl) Distamycinederivaten, werkwijze voor de bereiding ervan, alsmede farmaceutische preparaten, die deze derivaten bevatten.
NL192202B (nl) 2(1H)-pyridinonderivaten en farmaceutische preparaten die deze derivaten bevatten.
DE3262516D1 (en) Omega-cyano-1, omega-diphenyl azalcane derivatives, their preparation and pharmaceutical preparations containing them
NL7810865A (nl) 6,7-dialkoxy-4-piperidinochinazolinen, farmaceutische preparaten die ze bevatten, en werkwijzen voor de be- reiding daarvan.
NL193583B (nl) Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan.
NL930078I1 (nl) Aminederivaten werkwijze voor de bereiding daarvanen farmaceutische preparaten die deze bevatten
NL8601837A (nl) Poly-4-aminopyrrool-2-carboxamidoderivaten, werkwijze ter bereiding ervan, farmaceutische preparaten, die deze derivaten bevatten alsmede werkwijze voor de bereiding van de farmaceutische preparaten.
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
ZA821957B (en) Acylquinolinone derivatives, processes for their manufacture, pharmaceutical preparations containing them and their use
NL194431B (nl) Farmaceutische preparaten die ranitidine bevatten.
NL184833C (nl) 2-gesubstitueerd aminopyrimidinederivaten en farmaceutische preparaten die ze bevatten.
NL193541B (nl) 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
NZ221059A (en) Cycloalkyl substituted 4-pyridyl derivatives, pharmaceutical compositions and preparations
NL7702037A (nl) Werkwijze voor het bereiden van n-acetyl-n'-chloor- benzoylhydrazinederivaten, en van preparaten, die de derivaten bevatten.
NL192387B (nl) Zuivere silibininederivaten, werkwijze voor de bereiding daarvan en farmaceutisch preparaat dat een dergelijk derivaat bevat.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050905